Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
Authors
Keywords
-
Journal
BLOOD
Volume 124, Issue 2, Pages 204-210
Publisher
American Society of Hematology
Online
2014-05-29
DOI
10.1182/blood-2014-01-550244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relapses of thrombotic thrombocytopenic purpura after treatment with rituximab
- (2013) Jatinder Goyal et al. JOURNAL OF CLINICAL APHERESIS
- ADAMTS13 Antibody Depletion by Bortezomib in Thrombotic Thrombocytopenic Purpura
- (2013) Jake Shortt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab as prophylaxis in chronic relapsing thrombotic thrombocytopenic purpura
- (2012) Roberto C. Montoya et al. BLOOD COAGULATION & FIBRINOLYSIS
- Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
- (2012) Marie Scully et al. BRITISH JOURNAL OF HAEMATOLOGY
- Long-term management of acquired thrombotic thrombocytopenic purpura using serial plasma ADAMTS13 measurements
- (2012) Mary Ann Knovich et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Current management and therapeutical perspectives in thrombotic thrombocytopenic purpura
- (2012) Paul Coppo et al. PRESSE MEDICALE
- Autoimmune Thrombotic Microangiopathy: Advances in Pathogenesis, Diagnosis, and Management
- (2012) Han-Mou Tsai SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Rituximab maintenance for relapsed refractory thrombotic thrombocytopenic purpura
- (2012) Vinai C. Bhagirath et al. TRANSFUSION
- A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
- (2011) M. Scully et al. BLOOD
- Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
- (2011) Antoine Froissart et al. CRITICAL CARE MEDICINE
- Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab
- (2010) Jens Marcus Chemnitz et al. ANNALS OF HEMATOLOGY
- Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)
- (2010) H. B. Feys et al. BLOOD
- The effect of rituximab on humoral and cell mediated immunity and infection in the treatment of autoimmune diseases
- (2010) Nichola Cooper et al. BRITISH JOURNAL OF HAEMATOLOGY
- Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
- (2010) Paul Coppo et al. PLoS One
- LETTERS TO THE EDITOR: Successful long-term rituximab maintenance for a relapsing patient with idiopathic thrombotic thrombocytopenic purpura
- (2010) Mario Ojeda-Uribe et al. TRANSFUSION
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Complications of plasma exchange in patients treated for thrombotic thrombocytopenic purpura. IV. An additional study of 43 consecutive patients, 2005 to 2008
- (2009) TRANSFUSION
- Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
- (2008) J. E. Sadler BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search